Post-hypoxic Unstable Breathing in the C57BL/6J Mouse: Effects of Acetazolamide
We examined whether acetazolamide (ACZ), a carbonic anhydrase inhibitor, would alter post-hypoxic ventilatory behavior and periodic breathing in the C57BL/6J (B6) mouse. Experiments were performed with unanaesthetized, awake adult male B6 mice (n = 5, 2.5 months old, 21.3 ± 1.5 g, mean ± SD) and ventilatory behavior was measured using a flow through body plethysmography. Mice were given an intraperitoneal injection of either vehicle or ACZ (40 mg/kg) and one hour later exposed to 1 min of 8% O2-balance N2 (poikilocapnic hypoxia) or 12%-O2, 3% CO2-balance N2 (non-poikilocapnic hypoxia) followed by rapid reoxygenation (100% O2) of 5 minutes. One minute after reoxygenation, ACZ-treated animals exhibited post-hypoxic frequency decline (p < 0.05), a lower coefficient of variability for frequency (p < 0.001) and no tendency towards periodic breathing (p < 0.05), as compared to vehicle-treated animals. ACZ improves unstable breathing in the B6 model of periodic breathing, despite producing post-hypoxic frequency decline. Our speculation is that periodic breathing occurs through pathways independent of the A5 pontine area.
KeywordsSleep Apnea Central Sleep Apnea Carbonic Anhydrase Inhibitor Periodic Breathing Body Plethysmography
Unable to display preview. Download preview PDF.
- Younes, M. (1989) The physiologic basis of central apnea and periodic breathing. Curr. Pulmonol 10, 265–326.Google Scholar